4//SEC Filing
Santos David A 4
Accession 0001567619-22-001780
CIK 0001034842other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 8:45 PM ET
Size
7.3 KB
Accession
0001567619-22-001780
Insider Transaction Report
Form 4
Santos David A
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2022-01-24+50,000→ 60,000 total - Award
Stock Option (Right to Buy)
2022-01-24+100,000→ 100,000 totalExercise: $2.42Exp: 2032-01-24→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2022, with the first annual vest occurring on February 1, 2023.
- [F2]Includes 10,000 shares acquired under the Issuer's stock purchase plan.
- [F3]The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the reporting person's continuous service to the issuer through each such period.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001820066
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 8:45 PM ET
- Size
- 7.3 KB